HoxA10 Activators refer to a class of chemical compounds that possess the unique ability to interact with and modulate the activity of HoxA10, a member of the Hox gene family. Hox genes are a group of highly conserved transcription factors that play a fundamental role in embryonic development and pattern formation. HoxA10, in particular, is expressed in various tissues during early embryogenesis and is known for its involvement in specifying cell fate and regional identity along the anterior-posterior axis of the developing embryo. HoxA10 activators are compounds that can influence the expression, stability, or transcriptional activity of HoxA10, impacting cellular processes related to development, differentiation, and morphogenesis.
The mechanism of action of HoxA10 activators typically involves their capacity to modulate the transcriptional activity of HoxA10 or its interactions with co-factors and regulatory proteins. HoxA10 functions by binding to specific DNA sequences and regulating the expression of target genes that are essential for proper tissue and organ development. Activators may enhance or inhibit the binding of HoxA10 to its target gene promoters, affecting the expression of downstream genes involved in developmental processes. Additionally, they may influence the recruitment of co-factors or post-translational modifications of HoxA10, which can further regulate its function during embryogenesis. Understanding the properties and effects of HoxA10 activators is significant in the field of developmental biology, as it provides insights into the molecular mechanisms that govern embryonic development, tissue patterning, and cell fate determination. It contributes to our understanding of how specific compounds can influence the regulatory networks that shape the formation and function of various tissues and organs during development.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid modulates HOXA10 expression by interacting with retinoic acid receptors, influencing gene expression during embryonic development. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
β-Estradiol, a form of estrogen, regulates several HOX genes, including HOXA10, by binding to estrogen receptors, leading to altered transcriptional activity. | ||||||
Progesterone | 57-83-0 | sc-296138A sc-296138 sc-296138B | 1 g 5 g 50 g | $20.00 $52.00 $298.00 | 3 | |
Progesterone regulates HOXA10 expression in endometrial cells through its receptors, indirectly affecting HOXA10 expression. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
A histone deacetylase inhibitor that can indirectly affect HOXA10 expression through epigenetic modifications. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
A DNA methyltransferase inhibitor altering DNA methylation patterns, potentially leading to changes in HOXA10 expression. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Activates adenylate cyclase, increasing cAMP levels and potentially influencing HOXA10 expression through various signaling pathways. | ||||||